Kelly Laas

Ms. Kelly Laas

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2025 in Frontiers in Environmental Health
Verified
Journal Article
Open access
PDF file
KLKelly Laas
Kelly Laas
KBKimberly Vargas Barreto
Kimberly Vargas Barreto
EHElisabeth Hildt
Elisabeth Hildt
There has been a growing literature on exposome and environmental health-related research, public acceptance, and understanding of ecological health-related testing; however, it has remained underexplored, especially in the context of rapid testing. This study aims to fill this gap by gathering insights into what key stakeholders see as the primary ethical implications, benefits, and possible risks of environment-related tests. 32 interviews were conducted with potential users, medical providers, and ethicists, asking them about their perceptions of environment-related testing, who would benefit most from the research, and if these tests might detract focus from other, directly relevant health-related factors. The study found that the main concerns among these stakeholders include test reliability, the need for tests where the ecological factor being tested has a proven causality for human health, the possibility for individuals or communities to achieve change based on the test results, and the need for tests that foster social justice.

12 January 2026 in Frontiers in Antibiotics
Verified
Journal Article
Open access
PDF file
KLKelly Laas
Kelly Laas
KBKimberly Vargas Barreto
Kimberly Vargas Barreto
EHElisabeth Hildt
Elisabeth Hildt
Antibiotic resistance remains a significant public health concern. One possible solution is to develop a new type of highly accessible test for antibiotic resistance that can be rapidly and easily utilized. As new diagnostics for measuring antibiotic resistance continue to be developed, several key practical, ethical, and social factors must be considered, including the types of tests that might be useful, their potential beneficiaries, and the contexts in which they should be utilized. This study aims to gather insights from key stakeholders regarding the ethical implications, benefits, and potential risks associated with a hypothetical rapid antibiotic resistance test that may also be designed for home use. A total of 32 semi-structured interviews were conducted with three stakeholder groups: potential users, medical providers, and ethicists. While prospective users of the test were generally positive about the proposed test, this might reflect public acceptance of point of care/home tests in general, rather than one specifically measuring ABR. Medical providers and experts knowledgeable about the problems of antibiotic overuse quickly pointed out some drawbacks and areas of concern for home testing for ABR, offering helpful guidance on where further research and consideration are needed.